Mml Investors Services, LLC Supernus Pharmaceuticals, Inc. Transaction History

Mml Investors Services, LLC

  • $27.4 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$27.11 - $35.17 $171,280 - $222,204
6,318 New
6,318 $216,000
Q4 2022

Feb 13, 2023
BUY
$31.09 - $37.88 $175,067 - $213,302
5,631 New
5,631 $201,000
Q2 2022

Aug 12, 2022
SELL
$25.33 - $34.25 $164,467 - $222,385
-6,493 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$28.51 - $32.9 $22,437 - $25,892
-787 Reduced 10.81%
6,493 $210,000
Q4 2021

Feb 14, 2022
BUY
$26.37 - $34.22 $191,973 - $249,121
7,280 New
7,280 $212,000

Others Institutions Holding SUPN

# of Institutions
282
Shares Held
60.9M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.94B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Mml Investors Services, LLC Portfolio

Follow Mml Investors Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email